Creation of the IRT
3 employees + 3 volunteers
13 projects
Structure: 13 technical platforms and 6 technology centers
61 employees
Structure: Paris 600m2 (offices and labs) / Lyon 820m2 (offices and labs)
Teams spread over 6 locations in Lyon (Lyonbiopole, ANSES, IN2P3, Accinov and ISA) and at Institut Pasteur
86 employees
15 projects
New structure: 7 technological units and 4 thematic units
100 employees
Moving into the new building in Lyon with 2,200m2 of laboratories and 1,360m2 of offices, in addition to the 850m2 premises in Paris.
31 projects
Structure: 7 technological units + 1: Bioassays, Microsystems and Optical Engineering
4 programs: Antimicrobials, Diagnostic, Microbiome, Vaccines
110 employees
BIOASTER celebrated its 10th anniversary!
To create together...
Founders
Co-founding leaders
Funding supports
Public research institutions
Major of healthcare industry
The ecosystem
BIOASTER is an actor in or member of various networks that aim to facilitate the application of technological innovation in the health sector.
BIOASTER is at the heart of the health ecosystem in France. This positioning allows the Institute to provide its partners with knowledge of the networks that exist in the sector, both to identify and engage the most appropriate players in a project and to promote new synergies and complementarity that benefit all the parties concerned.
tem
sys-
tem
Support networks for innovation and technology transfer: FIT, competitiveness clusters, and SATT
BIOASTER has been part of this global competitiveness cluster since its creation in 2005. It supports projects and companies in the sector and aims to aid the development of technological innovations, products, and services to meet the health challenges of tomorrow.
- undertake discussions in order to identify opportunities for joint projects, and in particular projects in which BIOASTER would validate, and if appropriate, disseminate technologies developed by PULSALYS
- consider access for BIOASTER to the services offered by PULSALYS, in particular with respect to intellectual property management.
- discuss best practices regarding innovation, technology transfer, and the protection of research findings.
Thematic initiatives: Hub VPH, TWB, and APM
This first Veterinary Public Health hub was created on the basis of a common desire: to become a world-class reference center for Veterinary Public Health, and was driven by the strong collaborative tradition in the Auvergne-Rhône-Alpes region and recognition of the importance of addressing international Veterinary Public Health issues.
Cynbiome® undertakes preclinical R&D activities, focusing on the microbiome and infectious diseases.
BIOASTER is a player in the development of innovative technologies for healthcare purposes, bringing its expertise, means, and resources to the pursuit of these objectives, and is an enthusiastic participant in the partnership and collaborative approaches to the development of common objectives and projects.